The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.
Related Posts
Trump Holds Off on Tariffs, but Paves the Way for Future Trade Action
The president’s executive action on trade will keep all possibilities on the table, including eventual tariffs against China, Canada and Mexico.
California Tribal Casinos May Sue to Curb City Card Rooms
A new state law allows tribes to file suit against gambling venues they don’t operate, potentially shuttering them and jeopardizing local tax revenue.
World Economic Forum: Davos Braces for Political Drama as the World Warms
A new U.S. president’s promise to expand fossil fuels that is at odds with global ambitions to combat climate change will be a topic of […]